Alere i Influenza A & B test now available in Europe Alere Inc.

Alere i Influenza A & B test now available in Europe Alere Inc. The test is now commercially available in Austria, France, Spain, Switzerland, Germany, Italy and the united kingdom. Alere i also significantly expands screening possibilities by making innovative, rapid molecular testing technology available at the idea of care in addition to in laboratory settings dmae . Alere i Influenza A & B may be the first molecular diagnostic check that provides actionable, lab-accurate results in under quarter-hour on a user-friendly platform. Alere i testing for Strep A, C. Difficile, respiratory syncytial virus and chlamydia / gonorrhoea are in development.

Ron Zwanziger, Chairman, LEADER President and Officer of Alere said, We are pleased to report a very strong one fourth for Alere. Financial outcomes for the third quarter of 2013: Net income of $753.9 million for the 3rd quarter of 2013, in comparison to $691.4 million for the 3rd quarter of 2012.4 million for the 3rd quarter of 2013, compared to $692.3 million for the 3rd quarter of 2012. Net lack of $24.8 million attributable to common stockholders of Alere Inc., and respective net reduction per diluted common talk about of $0.30, for the 3rd quarter of 2013, compared to net loss of $9.2 million attributable to common stockholders of Alere Inc., and respective net loss per diluted common talk about of $0.11, for the 3rd quarter of 2012.